Gastritis | Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis

Gastritis research study

What is the primary objective of this study?

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription Weiqi decoction on Chronic Atrophic Gastritis.

Who is eligible to participate?

Inclusion Criteria: - Clinical diagnosis of Chronic Atrophic Gastritis - Male of female patients between 18-65 years old - Written informed consent Exclusion Criteria: - Combine with malignant pathology on epithelial dysplasia of gastric mucosa - Combine with duodenal ulcer or gastric ulcer - Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease. - Pregnancy or breast feeding women, or unwilling to have contraception.

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?


Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Drug:Weiqi decotionDecoction ,two times a day

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Weiqi decoction

low dose of Weiqi decoction

Study Status


Start Date: August 2009

Completed Date: July 2012

Phase: N/A

Type: Interventional


Primary Outcome: Symptoms and conditions of tongue and pulse,the gastroscopy and pathological change

Secondary Outcome: Indicates of liver and renal function

Study sponsors, principal investigator, and references

Principal Investigator: Xie Jianqun, Phd

Lead Sponsor: Shanghai University of Traditional Chinese Medicine


More information:

Discuss Gastritis